Research location
Province of Macerata
Italy
Advertisement
Research activity in Province of Macerata
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 40 trials and 40 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Province of Macerata
40 linked trials · page 1 of 1Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeNCT06486883 · 2025-06-30 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation
RECRUITING
DESTINY Breast Respond HER2-(Ultra)Low EuropeNCT05945732 · 2023-10-24 · 1 site observation
RECRUITING
A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin IcodecNCT07632404 · 2026-05-28 · 1 site observation
ENROLLING_BY_INVITATION
Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal MedicineNCT07727070 · 2025-12-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerNCT06112379 · 2023-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerNCT05654623 · 2023-03-03 · 1 site observation
ACTIVE_NOT_RECRUITING
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in ItalyNCT05755360 · 2023-02-21 · 1 site observation
COMPLETED
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerNCT05514054 · 2022-10-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerNCT05382286 · 2022-07-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerNCT05382299 · 2022-07-20 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)NCT05374512 · 2022-05-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerNCT04752332 · 2021-05-10 · 1 site observation
TERMINATED
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or SelexipagNCT04567602 · 2020-10-06 · 1 site observation
COMPLETED
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in ItalyNCT04463108 · 2020-06-23 · 1 site observation
COMPLETED
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerNCT04305496 · 2020-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeNCT04094415 · 2019-10-28 · 1 site observation
COMPLETED
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer PatientsNCT05730647 · 2019-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.NCT03330847 · 2018-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerNCT03431350 · 2018-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
MEtronomic TrEatment Option in Advanced bReast cAncerNCT02954055 · 2017-09-13 · 1 site observation
COMPLETED
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDONCT03227328 · 2017-08-02 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)NCT03036488 · 2017-03-07 · 1 site observation
COMPLETED
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody AvelumabNCT02926196 · 2016-06-17 · 1 site observation
COMPLETED
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerNCT02404051 · 2015-12-01 · 1 site observation
UNKNOWN
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsNCT02175446 · 2014-09-01 · 1 site observation
UNKNOWN
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsNCT02213744 · 2014-07-01 · 1 site observation
TERMINATED
A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH ProjectNCT01700556 · 2013-01-14 · 1 site observation
COMPLETED
Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous TreatmentNCT01530334 · 2012-07-01 · 1 site observation
COMPLETED
The COPD Patient Management European Trial (COMET)NCT01241526 · 2010-09-01 · 1 site observation
COMPLETED
The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)NCT01032304 · 2009-08-01 · 1 site observation
UNKNOWN
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerNCT01091168 · 2009-07-01 · 1 site observation
COMPLETED
A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With CancerNCT01240720 · 2008-09-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast CancerNCT00393939 · 2007-02-01 · 1 site observation
COMPLETED
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNCT00338247 · 2006-07-01 · 1 site observation
APPROVED_FOR_MARKETING
A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing ChemotherapyNCT02761642 · 2004-02-29 · 1 site observation
COMPLETED
Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)NCT00144170 · 2003-02-01 · 1 site observation
COMPLETED
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD PatientsNCT00144339 · 2002-12-01 · 1 site observation
COMPLETED
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected SubjectsNCT00146328 · 2001-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.